Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine and Temsirolimus in Older Patients With Relapsed or Refractory AML
NCT00775593Phase 2Completed
- Sponsor
- GIMEMA
- Start
- Dec 2008
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temsirolimus in acute myeloid leukemia (AML), sponsored by GIMEMA. Started Dec 2008; status: completed.
02
Drugs
temsirolimus
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00775593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00775593.